IHC analysis of tumor sections from Figure 3 also showed a robust recruitment of CD8+ cytotoxic Tc cells into the TME in STO-1-treated mice (Figure 8C,D), with much lower levels in Pac-treated mice. The gene discussed is CD8A; the disease is neoplasm.